Cargando…
Validation of a yellow fever vaccine model using data from primary vaccination in children and adults, re-vaccination and dose-response in adults and studies with immunocompromised individuals
BACKGROUND: An effective yellow fever (YF) vaccine has been available since 1937. Nevertheless, questions regarding its use remain poorly understood, such as the ideal dose to confer immunity against the disease, the need for a booster dose, the optimal immunisation schedule for immunocompetent, imm...
Autores principales: | Bonin, Carla Rezende Barbosa, Fernandes, Guilherme Côrtes, de Menezes Martins, Reinaldo, Camacho, Luiz Antonio Bastos, Teixeira-Carvalho, Andréa, da Mota, Licia Maria Henrique, de Lima, Sheila Maria Barbosa, Campi-Azevedo, Ana Carolina, Martins-Filho, Olindo Assis, dos Santos, Rodrigo Weber, Lobosco, Marcelo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733702/ https://www.ncbi.nlm.nih.gov/pubmed/33308151 http://dx.doi.org/10.1186/s12859-020-03845-3 |
Ejemplares similares
-
Occurrence of Autoimmune Diseases Related to the Vaccine against Yellow Fever
por: Oliveira, Ana Cristina Vanderley, et al.
Publicado: (2014) -
Serious adverse events associated with yellow fever vaccine
por: de Menezes Martins, Reinaldo, et al.
Publicado: (2015) -
Subdoses of 17DD yellow fever vaccine elicit equivalent virological/immunological kinetics timeline
por: Campi-Azevedo, Ana Carolina, et al.
Publicado: (2014) -
Duration of Humoral and Cellular Immunity 8 Years After Administration of Reduced Doses of the 17DD-Yellow Fever Vaccine
por: da Costa-Rocha, Ismael Artur, et al.
Publicado: (2019) -
Corrigendum: Duration of Humoral and Cellular Immunity 8 Years After Administration of Reduced Doses of the 17DD-Yellow Fever Vaccine
por: da Costa-Rocha, Ismael Artur, et al.
Publicado: (2019)